Upcoming Events: 

                                               RNA and AI Symposium (October 29, 2024)

                                               AI Driven Drug Discovery Summit (November 11-13, 2024)

Past Events:

October 3, 2024 Elevate Festival 

                                                Brendan Frey, Founder, CIO, Deep Genomics 

                                                Panel - From Lab to Market: Turning Academic Innovation into Commercial Success

September 4-5, 2024 RNA Leaders USA Conference

                                                Brendan Frey, Founder, CIO, Deep Genomics 

                                                Presentation - Pioneering an AI Foundation Model for the Discovery of Disease Mechanisms and RNA 

                                                Therapeutics

                                                Panel - The Future of RNA Therapeutics

January 12, 2022  Deep Genomics Company Presentation

                                                Brendan Frey, Founder, CEO, Deep Genomics 

                                                40th Annual J.P. Morgan Healthcare Conference

December 9, 2021 “The Convergence of Biotechnology and Technology: A Biotechs Panel” - Privates Panel

                                                Brendan Frey, Founder, CEO, Deep Genomics 

                                                Goldman Sachs Byte-ology

December 9, 2021  "Best practice for the oligonucleotide hit-to-lead process" -- Panel Moderator

                                                Jeffery Brown, Vice President and Head of Preclinical Research

                                                Oligonucleotide Therapeutics East Coast

December 4, 2021 “The Biotech Tree: Which biotech opportunities should we seize? Which risks must we avoid?" -- Panel

                                                Amit Deshwar, Vice President and Head of Predictive Systems

                                                Foresight Institute Vision Weekend 2021

November 10, 2021  "AI Breakthroughs at Deep Genomics" - Keynote Speaker 

                                                Brendan Frey, Founder and CEO, Deep Genomics 

                                                Vector Institute - Careers in AI: Health 

September 22, 2021 "Why AI will be the Foundation of 21st Century Medicine" - Keynote Speaker

                                                Brendan Frey, Founder and CEO, Deep Genomics

                                                World Muscle Society Annual Congress 2021, Opening Session

July 15, 2021  “Putting the Tech in Biotech: AI and Future Disruptors” Panel

                                                Brendan Frey, CEO, Deep Genomics

                                                William Blair Biotech Focus Conference 2021

May 20, 2021  Artificial Intelligence in Drug Discovery Panel

                                                Brendan Frey, CEO, Deep Genomics

                                                Citi Private Company Digital Health Conference 2021

December 4, 2020  A genetic medicine for Wilson disease

                                                Brendan Frey, CEO, Deep Genomics

                                                Wilson Disease Association Virtual Conference

September 28, 2020 Fireside chat on discovering therapies using AI

                                                Brendan Frey and Ferdinand Massari, CEO and CMO, Deep Genomics

                                                Oligonucleotide Therapeutics Society Annual Meeting, Virtual Conference

October 29, 2019 How AI is accelerating drug discovery

                                                Daniele Merico, Head of Target Identification, Deep Genomics

                                                DIA/FDA Meeting on Oligonucleotide Therapeutics, Washington DC

September 24, 2019 Deep Genomics nominates industry's first AI-discovered therapeutic candidate

                                                Brendan Frey, CEO, Deep Genomics

                                                Elevate Conference, Toronto

May 21, 2019 Accelerating target discovery and development using deep learning and AI

                                                Daniele Merico, Head of Target Identification, Deep Genomics

                                                TIDES Conference, San Diego

March 28, 2019 Accelerating drug development using AI

                                                Brendan Frey, CEO, Deep Genomics

                                                RNA & Oligonucleotide Therapeutics Conference, Cold Spring Harbor

October 25, 2018 How deep learning is transforming drug discovery

                                                Brendan Frey, CEO, Deep Genomics

                                                Re-Work Summit, Toronto

December 9, 2017 Why AI will make it possible to reprogram the human genome

                                                Brendan Frey, CEO, Deep Genomics

                                                Neural Information Processing Systems Conference, Los Angeles